Kenadion Injection 1 ml (Phytomenadione) Quantity:20 Ampoule/s with benefits typically noticeable within

with benefits typically noticeable within one to two weeks of consistent dosing

prior therapies and individual response

Pregnancy and lactation: The safety of Vinpocetine during pregnancy and breastfeeding has not been established

Although the drug was originally developed by Bayer AG

due to teratogenic risk

Kenadion Injection 1 ml (Phytomenadione) Quantity:20 Ampoule/s with benefits typically noticeable withinProduct Overview Kenadion Injection 1 ml contains Phytomenadione, the synthetic form of vitamin K1. It is formulated for parenteral administration and is indicated for the treatment of nutritional deficiencies that may arise from malabsorption, chronic antibiotic use, or inadequate dietary intake. The product is supplied by Samarth Pharma and is available in two strengths: 1 mg and 10 mg per injection. Each package includes a sterile vial ready for